Neuronal intranuclear inclusion disease with initial manifestation of intractable nausea and vomiting responsive to corticosteroids: a case report

Read full text Summarise with VIRAT
Authors: Long Luo, Li Zhu, Yong Liang, Ying Yuan, Lei Chen, Weiwen Peng, Gao Yang, Ronghe Yang
Cited by: 0
References: 33

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Neuronal intranuclear inclusion disease (NIID) can initially present with gastrointestinal symptoms as the sole or primary manifestation for decades before neurological signs emerge. We report the case of a 61-year-old woman with a 22-year history of drug-refractory, recurrent nausea and vomiting. Previous extensive gastrointestinal evaluations were unremarkable, and conventional therapies proved ineffective. The diagnosis of NIID was established on the basis of the following key findings: diffusion-weighted imaging revealed a characteristic “crown-like” hyperintensity at the corticomedullary junction; genetic analysis revealed a GGC repeat expansion in the NOTCH2NLC gene, with no abnormalities detected in FMR1 ; and skin biopsy demonstrated p62-positive intranuclear inclusions within sweat gland cells. The patient’s symptoms improved markedly with corticosteroid therapy but recurred upon repeated withdrawal. Subsequent initiation of a maintenance corticosteroid regimen resulted in sustained clinical stability, with only occasional mild symptom fluctuations over a six-month follow-up period. This case highlights that vomiting can be a prominent and early clinical feature of NIID. The condition should be considered in the differential diagnosis of patients with unexplained, refractory nausea and vomiting, for whom long-term corticosteroid therapy may represent a viable treatment strategy.

Fields of Study & Subjects

Genetic Neurodegenerative Diseases Neurological diseases and metabolism Lysosomal Storage Disorders Research

Publication details

Journal / source
Frontiers in Immunology
Volume
17
Pages
1782547–1782547
Publication date
18 March 2026
Language
EN